InvIOs GmbH | WebDisclosure

Basculer en Français

10940	Companies
239029	Keywords
167904	Articles
128527	Press releases

Home
Companies
InvIOs GmbH

BRIEF

published on 07/17/2024 at 10:05, 2 years 1 month ago

InvIOs sélectionne le candidat principal INV501 pour des études IND-habilitantes sur le glioblastome et le mélanome

Thérapie Contre Le Cancer Etudes Précliniques Mélanome INV501 Glioblastome
PRESS RELEASE

published on 07/17/2024 at 10:00, 2 years 1 month ago

invIOs selects INV501 lead candidate to progress into IND-enabling studies in glioblastoma and melanoma
invIOs selects INV501 lead candidate to progress into IND-enabling studies in glioblastoma and melanoma. The compound shows strong activation of tumor-specific T cells in preclinical testing

Melanoma IND-enabling Studies INV501 Glioblastoma InvIOs
PRESS RELEASE

published on 11/09/2023 at 11:30, 2 years 9 months ago

invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma
PRESS RELEASE

published on 09/05/2023 at 09:00, 3 years ago

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
PRESS RELEASE

published on 06/19/2023 at 14:30, 3 years 2 months ago

invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors
PRESS RELEASE

published on 04/18/2023 at 15:00, 3 years 4 months ago

invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023

Accesswire

Published on 09/08/2026 at 01:45, 1 hour 45 minutes ago

Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 2 days 23 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 4 hours ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 4 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 5 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000

View all ACCESSWIRE

EQS Group

Published on 09/07/2026 at 19:19, 8 hours 11 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 8 hours 30 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 8 hours 47 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 9 hours 30 minutes ago

E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 9 hours 45 minutes ago

VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

Les Echos

Published on 09/07/2026 at 19:55, 7 hours 34 minutes ago

TFF GROUP CREE TFF UPCYCLING
Published on 09/07/2026 at 19:00, 8 hours 30 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 8 hours 30 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 9 hours 25 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 9 hours 25 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026

View all LES ECHOS COMFI WIRE